Evidence map›Paper›PMID 39730143›Full record

ReviewJournal of industrial microbiology & biotechnology2024

Purple non-sulfur bacteria for biotechnological applications.

Hailee M Morrison, Arpita Bose

Abstract readReview
In one paragraph

Review in Journal of industrial microbiology & biotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Detection ofAntioxidants (Basel, Switzerland) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Hailee M MorrisonDepartment of Biology, Washington University in St. Louis, St. Louis, MO, USA.ORCID 0000-0002-2512-1824
Arpita BoseDepartment of Biology, Washington University in St. Louis, St. Louis, MO, USA.ORCID 0000-0002-7526-0988

Funding

Acoustic platform for separation, isolation, and enrichment in biomedical researchR01GM141344 · NIGMS · WASHINGTON UNIVERSITY · PI MEACHAM, JOHN MARK · 2022 to 2025
$1.5M
David and Lucile Packard Foundation 201563111Lawrence Livermore National Laboratory DEAC5207NA27344National Science Foundation 2021822NIGMS NIH HHS NIHR01GM141344NIGMS NIH HHS R01 GM141344U.S. Department of Defense W911NF-18-1-0037U.S. Department of Energy DESC0014613
6 · The paper itself

Abstract

In this review, we focus on how purple non-sulfur bacteria can be leveraged for sustainable bioproduction to support the circular economy. We discuss the state of the field with respect to the use of purple bacteria for energy production, their role in wastewater treatment, as a fertilizer, and as a chassis for bioplastic production. We explore their ability to serve as single-cell protein and production platforms for fine chemicals from waste materials. We also introduce more Avant-Garde technologies that leverage the unique metabolisms of purple bacteria, including microbial electrosynthesis and co-culture. These technologies will be pivotal in our efforts to mitigate climate change and circularize the economy in the next two decades. ONE-SENTENCE SUMMARY: Purple non-sulfur bacteria are utilized for a range of biotechnological applications, including the production of bio-energy, single cell protein, fertilizer, bioplastics, fine chemicals, in wastewater treatment and in novel applications like co-cultures and microbial electrosynthesis.

Indexed as

BiotechnologyProteobacteriaFertilizersWastewaterFertilizersWastewaterBioproductionBiotechnologyCircular economyPurple bacteriaSustainabilityWaste

Identifiers

PMID39730143
PMCPMC11730080

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.